Gunderson Dettmer advised sales agents Goldman Sachs & Co. LLC and SVB Securities on the deal. Goldman Sachs & Co. LLC and SVB Securities acted as sales agents in...
Arcus Biosciences’ $200 Million At-the-Market Offering
Zymergen Inc.’s $4 Billion Initial Public Offering
Freshfields served as issuer’s counsel to Zymergen Inc. The IPO values the company in excess of $4 billion. The company sold $575 million of shares of...